Novel compound antihypertensive preparation

Abstract

The invention discloses a novel compound antihypertensive preparation which comprises 50-200mg of irbesartan and 5-30mg of fosinopril. Aiming at solving the problem that currently when only one of irbesartan and fosinopril is used clinically, in order to ensure the curative effect, the dosage of the drug is increased, which leads to obvious increase of the side effects, the invention provides a novel compound preparation. Irbesartan and fosinopril are used together, so synergic and complementary curative effect can be produced. The novel compound antihypertensive preparation enhances the tolerance of the patient, improves the compliance and reduces the dosage and the adverse reaction, and is convenient to take and cheap in price.

Description

technical field [0001] The invention relates to the technical field of medicine and discloses a new compound antihypertensive preparation. Background technique [0002] Hypertension is the most common cardiovascular disease and a major public health problem worldwide. my country currently has about 100 million hypertensive patients. According to the epidemiological survey in 1991, the awareness rate of hypertension in my country's urban and rural areas was 36% and 13%, and the treatment rate was 17% and 5%, respectively. The form of hypertension prevention and treatment is quite severe. According to the forecast of WTO, by 2020, non-communicable diseases will account for 79% of the causes of death in my country, among which cardiovascular diseases will take the first place. [0003] Commonly used antihypertensive drugs include the angiotensin receptor antagonist irbesartan and the angiotensin converting enzyme inhibitor fosinopril. [0004] Irbesartan (Irbesartan), the ch...

AI Technical Summary

Problems solved by technology

[0026] The product of the present invention overcomes that when irbesartan and fosinopril are used clinically, the drug dosage is increased in order to ensure the curative effect when a s

Images